source
- FDA proposal to drop adequate provision could effectively ban prescription drug adsFDA staff are proposing to eliminate the adequate provision requirement in direct-to-consumer prescription-drug advertisements. The adequate provision currently obliges advertisers to present a bal…
- Pharma industry backs FDA NGS guidance but seeks clarification on off-target data and manufacturing changesThe pharmaceutical sector has broadly endorsed the FDA's recent guidance on using next‑generation sequencing to evaluate the safety of human gene‑therapy products. Despite this support, companies…